Hepatic iNKT cells facilitate colorectal cancer metastasis by inducing a fibrotic niche in the liver
The liver is an important metastatic organ that contains many innate immune cells, yet little is known about their role in anti-metastatic defense. We investigated how invariant natural killer T (iNKT) cells influence colorectal cancer-derived liver metastasis using different models in immunocompetent mice. We found that hepatic iNKT cells promote metastasis by creating a supportive niche for disseminated cancer cells. Mechanistically, iNKT cells respond to disseminating cancer cells by producing the fibrogenic cytokines interleukin-4 (IL-4) and IL-13 in a T cell receptor-independent manner. Selective abrogation of IL-4 and IL-13 sensing in hepatic stellate cells prevented their transdifferentiation into extracellular matrix-producing myofibroblasts, which hindered metastatic outgrowth of disseminated cancer cells. This study highlights a novel tumor-promoting axis driven by iNKT cells in the initial stages of metastasis.
Authors
- Virginia Cecconi
- Maries van den Broek (ORCID: https://orcid.org/0000-0002-9489-3692)
- Marc Nater (ORCID: https://orcid.org/0000-0002-5487-0998)
- Giulia Lucchiari
- A. Calvanese (ORCID: https://orcid.org/0009-0004-4219-7566)
- Michael David Brügger (ORCID: https://orcid.org/0000-0001-8792-2187)
- Paulo Pereira (ORCID: https://orcid.org/0000-0002-9908-2290)
- Tomáš Valenta (ORCID: https://orcid.org/0000-0002-3043-1835)
- Hakan Köksal (ORCID: https://orcid.org/0000-0002-6745-1442)
- Despoina Dimakou
- Christoph Schneider (ORCID: https://orcid.org/0000-0002-0452-2960)
- M. Herbst (ORCID: https://orcid.org/0000-0001-9664-9119)
- Geo Forni
Institutions
- University of Zurich (CH)
Publication Details
- Journal
- iScience
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.isci.2025.112364
- Citations
- 3
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Krebsliga Schweiz
- Universität Zürich
- Hartmann Müller-Stiftung für Medizinische Forschung